Analyze Diet
Animals : an open access journal from MDPI2022; 12(24); 3547; doi: 10.3390/ani12243547

Evaluation of Eosinopenia as a SIRS Biomarker in Critically Ill Horses.

Abstract: Systemic inflammatory response syndrome (SIRS) is a very common finding in critically ill patients. To accurately identify patients with SIRS and those who need intensive care, several markers have been evaluated, including cortisol, WBC or lactate. It is widely known that a stress leukogram includes eosinopenia as one of its main markers (neutrophilia, eosinopenia, lymphopenia and mild monocytes). It is known that cortisol concentration in plasma is the main stress biomarker and is strongly correlated with the severity of disease in horses. However, it is not possible to measure this parameter routinely in clinical conditions. Hence, in this study it was hypothesized that the eosinophil count could be a reliable parameter to identify critically ill horses. Horses included in this study were divided into three groups: Group A (sick horses received at the Emergency Unit which did not fulfil the criteria for SIRS), Group B (horses that meet two or more criteria for inclusion in the definition of SIRS) and a control group of healthy horses. In this study, horses with SIRS showed lower eosinophil counts than healthy horses. Moreover, non-surviving horses exhibited lower eosinophil counts than survivors. Eosinopenia could be used to identify horses with SIRS and can be useful as a prognostic marker.
Publication Date: 2022-12-15 PubMed ID: 36552467PubMed Central: PMC9774166DOI: 10.3390/ani12243547Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigates the potential of using eosinopenia – the reduced number of a type of white blood cells known as eosinophils – as a recognizable biomarker for Systemic Inflammatory Response Syndrome (SIRS) in critically ill horses. The study supports the assertion that eosinopenia can be used to identify horses suffering from SIRS and predicts survival outcomes.

Objectives and Hypothesis

  • The principle objective of the study was to ascertain the credibility of eosinopenia as a biomarker for SIRS in critically ill horses.
  • Most traditional methods of identifying SIRS involve markers like cortisol, White Blood Cells (WBC), or lactate. However, the researchers hypothesized that eosinophil counts could serve as a practical parameter in clinical conditions where measuring cortisol isn’t feasible.

Methodology

  • The study encompassed three groups of horses: Group A (ill horses that did not meet the criteria for SIRS upon arrival at the Emergency Unit), Group B (horses meeting two or more criteria for SIRS), and a control group consisting of healthy horses.

Findings

  • The results indicated that horses diagnosed with SIRS displayed lower eosinophil counts than healthy horses.
  • Further, eosinophil counts were found to be significantly lower in non-surviving than in surviving horses.

Conclusion

  • The research provides strong evidence to suggest that eosinopenia effectively identifies horses with SIRS.
  • Moreover, it may be used as a prognostic marker, indicating the likelihood of a horse surviving the critical illness.

Cite This Article

APA
Martín-Cuervo M, Gracia-Calvo LA, Macías-García B, Ezquerra LJ, Barrera R. (2022). Evaluation of Eosinopenia as a SIRS Biomarker in Critically Ill Horses. Animals (Basel), 12(24), 3547. https://doi.org/10.3390/ani12243547

Publication

ISSN: 2076-2615
NlmUniqueID: 101635614
Country: Switzerland
Language: English
Volume: 12
Issue: 24
PII: 3547

Researcher Affiliations

Martín-Cuervo, María
  • Grupo MECIAN, Departamento de Medicina Animal, Facultad de Veterinaria, Campus de Cáceres, Universidad de Extremadura, 10003 Cáceres, Spain.
Gracia-Calvo, Luis Alfonso
  • Veterinary Teaching Hospital, University of Helsinki, Koetilankuja 1, 00790 Helsinki, Finland.
Macías-García, Beatriz
  • Grupo MINVET, Departamento de Medicina Animal, Facultad de Veterinaria, Campus de Cáceres, Universidad de Extremadura, 10003 Cáceres, Spain.
Ezquerra, Luis Javier
  • Grupo MECIAN, Departamento de Medicina Animal, Facultad de Veterinaria, Campus de Cáceres, Universidad de Extremadura, 10003 Cáceres, Spain.
Barrera, Rafael
  • Grupo MINVET, Departamento de Medicina Animal, Facultad de Veterinaria, Campus de Cáceres, Universidad de Extremadura, 10003 Cáceres, Spain.

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 51 references
  1. Brink A, Alsma J, Verdonschot RJCG, Rood PPM, Zietse R, Lingsma HF, Schuit SCE. Predicting mortality in patients with suspected sepsis at the Emergency Department; A retrospective cohort study comparing qSOFA, SIRS and National Early Warning Score.. PLoS One 2019;14(1):e0211133.
  2. Roy MF, Kwong GP, Lambert J, Massie S, Lockhart S. Prognostic Value and Development of a Scoring System in Horses With Systemic Inflammatory Response Syndrome.. J Vet Intern Med 2017 Mar;31(2):582-592.
    doi: 10.1111/jvim.14670pmc: PMC5354005pubmed: 28207163google scholar: lookup
  3. Sheats MK. A Comparative Review of Equine SIRS, Sepsis, and Neutrophils.. Front Vet Sci 2019;6:69.
    doi: 10.3389/fvets.2019.00069pmc: PMC6424004pubmed: 30931316google scholar: lookup
  4. Wilkins PA. What's in a word? The need for SIRS and sepsis definitions in equine medicine and surgery.. Equine Vet J 2018 Jan;50(1):7-9.
    doi: 10.1111/evj.12780pubmed: 29193295google scholar: lookup
  5. Corley KT, Donaldson LL, Furr MO. Arterial lactate concentration, hospital survival, sepsis and SIRS in critically ill neonatal foals.. Equine Vet J 2005 Jan;37(1):53-9.
    doi: 10.2746/0425164054406856pubmed: 15651735google scholar: lookup
  6. Stewart AJ, Hackett E, Bertin FR, Towns TJ. Cortisol and adrenocorticotropic hormone concentrations in horses with systemic inflammatory response syndrome.. J Vet Intern Med 2019 Sep;33(5):2257-2266.
    doi: 10.1111/jvim.15620pmc: PMC6766528pubmed: 31512777google scholar: lookup
  7. Lambert JL, Fernandez NJ, Roy MF. Association of Presence of Band Cells and Toxic Neutrophils with Systemic Inflammatory Response Syndrome and Outcome in Horses with Acute Disease.. J Vet Intern Med 2016 Jul;30(4):1284-92.
    doi: 10.1111/jvim.13968pmc: PMC5089578pubmed: 27214343google scholar: lookup
  8. Hinchcliff KW, Rush BR, Farris JW. Evaluation of plasma catecholamine and serum cortisol concentrations in horses with colic.. J Am Vet Med Assoc 2005 Jul 15;227(2):276-80.
    doi: 10.2460/javma.2005.227.276pubmed: 16047666google scholar: lookup
  9. Regazzoni CJ, Khoury M, Irrazabal C, Myburg C, Galvalisi NR, O'Flaherty M, Sarquis SG, Poderoso JJ. Neutropenia and the development of the systemic inflammatory response syndrome.. Intensive Care Med 2003 Jan;29(1):135-8.
    doi: 10.1007/s00134-002-1560-7pubmed: 12528035google scholar: lookup
  10. Bass DA, Gonwa TA, Szejda P, Cousart MS, DeChatelet LR, McCall CE. Eosinopenia of acute infection: Production of eosinopenia by chemotactic factors of acute inflammation.. J Clin Invest 1980 Jun;65(6):1265-71.
    doi: 10.1172/JCI109789pmc: PMC371463pubmed: 7410543google scholar: lookup
  11. Zappert J. Ueber das Vorkommen der Eosinophilen Zellen in menschlichen Blute. Z. Klin. Med. 1893;23:227–308.
  12. Simon CE. A Manual of Clinical Diagnosis. 1st ed. Vol. 53 Henry Klimpton; London, UK: 1922.
  13. Dalton AJ, Selye H. The blood picture during the alarm reaction. Folia Haematol. 1939;62:397–407.
  14. Niinistö KE, Korolainen RV, Raekallio MR, Mykkänen AK, Koho NM, Ruohoniemi MO, Leppäluoto J, Pösö AR. Plasma levels of heat shock protein 72 (HSP72) and beta-endorphin as indicators of stress, pain and prognosis in horses with colic.. Vet J 2010 Apr;184(1):100-4.
    doi: 10.1016/j.tvjl.2009.01.011pubmed: 19237301google scholar: lookup
  15. Gil H, Magy N, Mauny F, Dupond JL. [Value of eosinopenia in inflammatory disorders: an "old" marker revisited].. Rev Med Interne 2003 Jul;24(7):431-5.
    doi: 10.1016/S0248-8663(03)00138-3pubmed: 12829215google scholar: lookup
  16. Altman LC, Hill JS, Hairfield WM, Mullarkey MF. Effects of corticosteroids on eosinophil chemotaxis and adherence.. J Clin Invest 1981 Jan;67(1):28-36.
    doi: 10.1172/JCI110024pmc: PMC371568pubmed: 7005265google scholar: lookup
  17. Abidi K, Khoudri I, Belayachi J, Madani N, Zekraoui A, Zeggwagh AA, Abouqal R. Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units.. Crit Care 2008;12(2):R59.
    doi: 10.1186/cc6883pmc: PMC2447615pubmed: 18435836google scholar: lookup
  18. Kim YH, Park HB, Kim MJ, Kim HS, Lee HS, Han YK, Kim KW, Sohn MH, Kim KE. Prognostic usefulness of eosinopenia in the pediatric intensive care unit.. J Korean Med Sci 2013 Jan;28(1):114-9.
    doi: 10.3346/jkms.2013.28.1.114pmc: PMC3546089pubmed: 23341721google scholar: lookup
  19. Bone RC. The pathogenesis of sepsis.. Ann Intern Med 1991 Sep 15;115(6):457-69.
    doi: 10.7326/0003-4819-115-6-457pubmed: 1872494google scholar: lookup
  20. Terradas R, Grau S, Blanch J, Riu M, Saballs P, Castells X, Horcajada JP, Knobel H. Eosinophil count and neutrophil-lymphocyte count ratio as prognostic markers in patients with bacteremia: a retrospective cohort study.. PLoS One 2012;7(8):e42860.
  21. Wibrow BA, Ho KM, Flexman JP, Keil AD, Kohrs DL. Eosinopenia as a diagnostic marker of bloodstream infection in hospitalised paediatric and adult patients: a case-control study.. Anaesth Intensive Care 2011 Mar;39(2):224-30.
    doi: 10.1177/0310057X1103900211pubmed: 21485670google scholar: lookup
  22. Yip B, Ho KM. Eosinopenia as a predictor of unexpected re-admission and mortality after intensive care unit discharge.. Anaesth Intensive Care 2013 Mar;41(2):231-41.
    doi: 10.1177/0310057X1304100130pubmed: 23530790google scholar: lookup
  23. Shaaban H, Daniel S, Sison R, Slim J, Perez G. Eosinopenia: Is it a good marker of sepsis in comparison to procalcitonin and C-reactive protein levels for patients admitted to a critical care unit in an urban hospital?. J Crit Care 2010 Dec;25(4):570-5.
    doi: 10.1016/j.jcrc.2010.03.002pubmed: 20435431google scholar: lookup
  24. Deibener-Kaminsky J, Lesesve JF, Kaminsky P. Leukocyte differential for acute abdominal pain in adults.. Lab Hematol 2011 Mar;17(1):1-5.
    doi: 10.1532/LH96.10023pubmed: 21421538google scholar: lookup
  25. Hubert J. Equine eosinophils -- why do they migrate?. Vet J 2006 May;171(3):389-92.
    doi: 10.1016/j.tvjl.2005.08.003pubmed: 16600646google scholar: lookup
  26. Benarafa C, Collins ME, Hamblin AS, Cunningham FM. Role of the chemokine eotaxin in the pathogenesis of equine sweet itch.. Vet Rec 2002 Dec 7;151(23):691-3.
    pubmed: 12503787
  27. Lin Y, Rong J, Zhang Z. Silent existence of eosinopenia in sepsis: a systematic review and meta-analysis.. BMC Infect Dis 2021 May 24;21(1):471.
    doi: 10.1186/s12879-021-06150-3pmc: PMC8142617pubmed: 34030641google scholar: lookup
  28. Allen SE, Holm JL. Lactate: Physiology and clinical utility. J. Vet. Emerg. Crit. Care. 2008;18:123–132.
  29. Dunkel B, Kapff JE, Naylor RJ, Boston R. Blood lactate concentrations in ponies and miniature horses with gastrointestinal disease.. Equine Vet J 2013 Nov;45(6):666-70.
    doi: 10.1111/evj.12043pubmed: 23451985google scholar: lookup
  30. Tennent-Brown BS, Wilkins PA, Lindborg S, Russell G, Boston RC. Sequential plasma lactate concentrations as prognostic indicators in adult equine emergencies.. J Vet Intern Med 2010 Jan-Feb;24(1):198-205.
  31. Delesalle C, Dewulf J, Lefebvre RA, Schuurkes JA, Proot J, Lefere L, Deprez P. Determination of lactate concentrations in blood plasma and peritoneal fluid in horses with colic by an Accusport analyzer.. J Vet Intern Med 2007 Mar-Apr;21(2):293-301.
  32. Borchers A, Wilkins PA, Marsh PM, Axon JE, Read J, Castagnetti C, Pantaleon L, Clark C, Qura'n L, Belgrave R, Trachsel D, Levy M, Bedenice D, Saulez MN, Boston RC. Association of admission L-lactate concentration in hospitalised equine neonates with presenting complaint, periparturient events, clinical diagnosis and outcome: a prospective multicentre study.. Equine Vet J Suppl 2012 Feb;(41):57-63.
  33. Castagnetti C, Pirrone A, Mariella J, Mari G. Venous blood lactate evaluation in equine neonatal intensive care.. Theriogenology 2010 Feb;73(3):343-57.
  34. Smanik LE, Moser DK, Rothers KP, Hackett ES. Serial venous lactate measurement following gastrointestinal surgery in horses.. J Vet Sci 2022 Sep;23(5):e66.
    doi: 10.4142/jvs.22038pmc: PMC9523334pubmed: 36038187google scholar: lookup
  35. Tennent-Brown BS. Interpreting lactate measurement in critically ill horses: diagnosis, treatment, and prognosis.. Compend Contin Educ Vet 2012 Jan;34(1):E2.
    pubmed: 22271469
  36. Peloso JG, Cohen ND. Use of serial measurements of peritoneal fluid lactate concentration to identify strangulating intestinal lesions in referred horses with signs of colic.. J Am Vet Med Assoc 2012 May 15;240(10):1208-17.
    doi: 10.2460/javma.240.10.1208pubmed: 22559111google scholar: lookup
  37. Latson KM, Nieto JE, Beldomenico PM, Snyder JR. Evaluation of peritoneal fluid lactate as a marker of intestinal ischaemia in equine colic.. Equine Vet J 2005 Jul;37(4):342-6.
    doi: 10.2746/0425164054529319pubmed: 16028624google scholar: lookup
  38. Burguez PN, Ousey J, Cash RS, Rossdale PD. Changes in blood neutrophil and lymphocyte counts following administration of cortisol to horses and foals.. Equine Vet J 1983 Jan;15(1):58-60.
  39. Jackson ML. Veterinary Clinical Pathology: An introduction. 1st ed. Wiley-Blackwell; Ames, IA, USA: 2007. The Leukocytes; pp. 55–80.
  40. Cowell RL, Tyler RD. Cytology and Hematology of the Horse. 2nd ed. Mosby, Inc.; St. Louis, MO, USA: 2002.
  41. Blood DC, Radostits OM. Veterinary Medicine. 7th ed. Bailliere Tindall; Filadelfia, PA, USA: 1989.
  42. Prittie J. Optimal endpoints of resuscitation and early goal-directed therapy. J. Vet. Emerg. Crit. Care. 2006;16:329–339.
  43. Rimmer E, Garland A, Kumar A, Doucette S, Houston BL, Menard CE, Leeies M, Turgeon AF, Mahmud S, Houston DS, Zarychanski R. White blood cell count trajectory and mortality in septic shock: a historical cohort study.. Can J Anaesth 2022 Oct;69(10):1230-1239.
    doi: 10.1007/s12630-022-02282-5pmc: PMC9334545pubmed: 35902458google scholar: lookup
  44. Mao Y, Qian Y, Sun X, Li N, Huang H. Eosinopenia Predicting Long-term Mortality in Hospitalized Acute Exacerbation of COPD Patients with Community-acquired Pneumonia-A Retrospective Analysis.. Int J Chron Obstruct Pulmon Dis 2021;16:3551-3559.
    doi: 10.2147/COPD.S347948pmc: PMC8722564pubmed: 35002227google scholar: lookup
  45. Tanni F, Akker E, Zaman MM, Figueroa N, Tharian B, Hupart KH. Eosinopenia and COVID-19.. J Am Osteopath Assoc 2020 Jul 16;.
    doi: 10.7556/jaoa.2020.091pubmed: 32672799google scholar: lookup
  46. Zhao HM, Qin WQ, Wang PJ, Wen ZM. Eosinopenia is a predictive factor for the severity of acute ischemic stroke.. Neural Regen Res 2019 Oct;14(10):1772-1779.
    doi: 10.4103/1673-5374.258411pmc: PMC6585555pubmed: 31169195google scholar: lookup
  47. Perlini S, Ciprandi G, Castagnoli R, Licari A, Marseglia GL. Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019.. Allergy Asthma Proc 2020 Nov 1;41(6):e80-e82.
    doi: 10.2500/aap.2020.41.200079pubmed: 33109314google scholar: lookup
  48. Kolkhir P, Church MK, Altrichter S, Skov PS, Hawro T, Frischbutter S, Metz M, Maurer M. Eosinopenia, in Chronic Spontaneous Urticaria, Is Associated with High Disease Activity, Autoimmunity, and Poor Response to Treatment.. J Allergy Clin Immunol Pract 2020 Jan;8(1):318-325.e5.
    doi: 10.1016/j.jaip.2019.08.025pubmed: 31472293google scholar: lookup
  49. von Meijenfeldt GCI, Chary S, van der Laan MJ, Zeebregts CJAM, Christopher KB. Eosinopenia and post-hospital outcomes in critically ill non-cardiac vascular surgery patients.. Nutr Metab Cardiovasc Dis 2019 Aug;29(8):847-855.
    doi: 10.1016/j.numecd.2019.05.061pubmed: 31248714google scholar: lookup
  50. Alkhalil M, Kearney A, Hegarty M, Stewart C, Devlin P, Owens CG, Spence MS. Eosinopenia as an Adverse Marker of Clinical Outcomes in Patients Presenting with Acute Myocardial Infarction.. Am J Med 2019 Dec;132(12):e827-e834.
    doi: 10.1016/j.amjmed.2019.05.021pubmed: 31152721google scholar: lookup
  51. Partouche B, Pepin M, de Farcy PM, Kahn JE, Sawczynski B, Lechowski L, Teillet L, Barbot F, Herr M, Davido B. Persistent eosinopenia is associated with in-hospital mortality among older patients: unexpected prognostic value of a revisited biomarker.. BMC Geriatr 2021 Oct 14;21(1):557.
    doi: 10.1186/s12877-021-02515-0pmc: PMC8516088pubmed: 34649512google scholar: lookup

Citations

This article has been cited 1 times.
  1. Villalba-Orero M, Contreras-Aguilar MD, Cerón JJ, Fuentes-Romero B, Valero-González M, Martín-Cuervo M. Association between Eosinophil Count and Cortisol Concentrations in Equids Admitted in the Emergency Unit with Abdominal Pain. Animals (Basel) 2024 Jan 4;14(1).
    doi: 10.3390/ani14010164pubmed: 38200895google scholar: lookup